Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2005
03/17/2005WO2005024377A2 Assay for detecting changes in mitochondrial membrane integrity and method of using same
03/17/2005WO2005024375A2 Sample module comprising a spare battery
03/17/2005WO2005024374A2 Process and device based on intelligent systems - artificial intelligence - artificial neural nets, for determination and control in real time of contaminants in physical and/or chemical and/or biological systems
03/17/2005WO2005024351A2 Real time determination of gas solubility and related parameters in manufacturing processes
03/17/2005WO2005024065A2 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same
03/17/2005WO2005024063A1 Method of diagnosis of obesity
03/17/2005WO2005024059A2 Methods for identifying compounds for inhibiting fever
03/17/2005WO2005024058A2 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
03/17/2005WO2005024057A1 Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell
03/17/2005WO2005024055A1 Methods of diagnosis and prognosis of ovarian cancer ii
03/17/2005WO2005024054A1 Diagnostic marker for ovarian cancer
03/17/2005WO2005024052A1 Method of determining amount of cholesterol ester
03/17/2005WO2005024050A1 Analytical methods for determination of proteolytic cleavage at specific sites
03/17/2005WO2005024043A2 Methods for identifying, diagnosing, and predicting survival of lymphomas
03/17/2005WO2005024041A2 Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins
03/17/2005WO2005024040A2 TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE: MINIMIZED DERIVATIVES OF PEPTIDE ANTIBIOTIC MccJ25
03/17/2005WO2005024026A1 Recombinant duffy antigens, fusions thereof, and use for detection of antibodies
03/17/2005WO2005024023A1 Brain tumor marker and method of diagnosing brain tumor
03/17/2005WO2005024022A1 Tick engorgement factor proteins
03/17/2005WO2005024003A1 Development of an anionic sensor for living cells : application to the human glycine receptor
03/17/2005WO2005023987A2 Cell-based assays for determining drug action
03/17/2005WO2005023985A2 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
03/17/2005WO2005023961A1 Novel fine fluorescent particle
03/17/2005WO2005023915A1 Hydrophobic object comprising a grid of hydrophilic regions, production of said object, and use of the same
03/17/2005WO2005023870A1 ANTIBODY RECOGNIZING TGF-β ACTIVATION CONTROLLING REGION SECTION
03/17/2005WO2005023864A1 Peptide-based immunization therapy for treatment of atherosclerosis
03/17/2005WO2005023863A1 Test system for the identification of apj receptor ligands
03/17/2005WO2005023859A1 A protein involved in carcinoma
03/17/2005WO2005023855A2 K203 gene and protein
03/17/2005WO2005023847A1 COMPOSITION FOR PROTECTING PROTEINS DEGRADATION COMPRISING SMALL HEAT SHOCK PROTEINS (sHSPs) AND METHOD OF TWO-DIMENSIONAL GEL ELECTROPHORESIS USING THE sHSPs
03/17/2005WO2005023831A1 Detection of cholesterol ozonation products
03/17/2005WO2005023816A2 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compouds and uses thereof
03/17/2005WO2005023311A2 Novel targets for the treatment of retina diseases
03/17/2005WO2005023305A2 Modulating cell activity by using an agent that reduces the level of cholesterol within a cell
03/17/2005WO2005023301A1 Remedy and detection drug for bile duct cancer
03/17/2005WO2005023295A2 Naturally processed immunodominant peptides derived from neisseria meningitidis porin a protein and their use
03/17/2005WO2005023291A2 Use of glp1-agonists in the treatment of patients with type i diabetes
03/17/2005WO2005023286A1 Medical agent for prevention and/or treatment of alzheimer disease
03/17/2005WO2005023256A1 Use of gabaa receptor agonists for the treatment of hearing, vestibular and attention disorders, intention tremor and restless leg syndrome
03/17/2005WO2005023232A2 Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders.
03/17/2005WO2005023231A1 Polypyrimidine tract binding protein promotes insulin secretory granule biogenesis
03/17/2005WO2005023205A2 Compositions and methods for yersinia pestis treatment
03/17/2005WO2005023202A2 Tumor suppressor lkb1 kinase directly activates amp-activated kinase
03/17/2005WO2005023199A2 Socs-3 promoter methylation in cancer
03/17/2005WO2005023186A2 Methods of identifying agents that inhibit the growth of cancer cells
03/17/2005WO2005008238A3 Method and device for the analysis of living reaction media
03/17/2005WO2005008229A3 Device for measuring the glass transition temperature of a polymer film
03/17/2005WO2005005955A8 Specific detection of chitin using chitin-binding domain
03/17/2005WO2005003379A3 Automatic large-scale screening of cells secreting monoclonal antibodies
03/17/2005WO2005001462A8 System and method for determining an abused sensor during analyte measurement in a biological fluid
03/17/2005WO2004113917A3 Method and reagent for producing narrow, homogenous reagent strips
03/17/2005WO2004113909A8 System and method for coding information on a biosensor test strip
03/17/2005WO2004111643A3 Patterns for a skeletal system
03/17/2005WO2004111217A3 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
03/17/2005WO2004110647A3 Microfluidic water analytical device
03/17/2005WO2004109254A3 Fullerene-based maldi matrices for peptides and proteins
03/17/2005WO2004106939A3 Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
03/17/2005WO2004104221A3 Methods and kits for quantifying metabolites or analytes
03/17/2005WO2004103313A3 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tpa) and tpa inhibitors useful therein
03/17/2005WO2004099424B1 Enrichment of enzymatic cleavage products
03/17/2005WO2004099395A3 A method for the generation of neural progenitor cells
03/17/2005WO2004096120A3 Compounds that selectively bind to membranes of apoptotic cells
03/17/2005WO2004092735A3 Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
03/17/2005WO2004092194A3 Chimeric polypeptides and their use
03/17/2005WO2004088326A3 Gastrin hormone immunoassays
03/17/2005WO2004087737A3 Omega-3 fatty acid assays for disease risk assessment
03/17/2005WO2004086052A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a2b (adora2b)
03/17/2005WO2004084797A3 Type 2 diabetes mellitus-associated gene and utilization of the same
03/17/2005WO2004083867A3 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
03/17/2005WO2004083866A8 Method for diagnosing lung transplantation rejection
03/17/2005WO2004082608A9 Ligands for tgf-beta binding proteins and uses thereof
03/17/2005WO2004082455A3 Method for detecting alzheimer’s disease and corresponding peptides and detection reagents
03/17/2005WO2004076473A3 Androgen receptor interacting peptides
03/17/2005WO2004072605A3 Method for the characterization of proteins, isolated proteins and uses therefore
03/17/2005WO2004072098A3 Immunocompromised rodents as dual color tumor models
03/17/2005WO2004071399A3 Modulation of atp production or content in the hypothalamus
03/17/2005WO2004070355B1 Wafer inspection using a nonvibrating contact potential difference probe (nonvibrating kelvin probe)
03/17/2005WO2004068130A3 Method and device for the qualitative and/or quantitative determination of a protein and/or peptide pattern of a fluid sample, which has been taken from the human or animal body
03/17/2005WO2004063696A3 Measuring and testing continuous elongated textile material
03/17/2005WO2004056862A3 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
03/17/2005WO2004048929B1 High throughput screening with parallel vibrational spectroscopy
03/17/2005WO2004046164A3 Unique recognition sequences and methods of use thereof in protein analysis
03/17/2005WO2004039963A3 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
03/17/2005WO2004038416A8 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6)
03/17/2005WO2004032850A3 Uses of human zven antagonists
03/17/2005WO2004025259A3 Site-specific labeling of affinity tags in fusion proteins
03/17/2005WO2004016171A9 Device and method for in vitro determination of analyte concentrations within body fluids
03/17/2005WO2003097811A3 Cellular gene targets for controlling cell growth
03/17/2005WO2003089899A3 Probes for detecting tumor cells
03/17/2005WO2003087760A3 Methods for detecting bcr-abl signaling activity in tissues using phospho- specific antibodies
03/17/2005WO2003081201A3 Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
03/17/2005WO2003078575A3 Molecular switches and methods for making and using the same
03/17/2005WO2003061564A8 Gene expression profiles in liver disease
03/17/2005WO2003060069A3 Compositions and methods relating to hepatic specific genes and proteins
03/17/2005WO2003054215A3 Therapeutic protein and nucleic acid
03/17/2005WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
03/17/2005US20050060764 Mouse model for bone metabolism
03/17/2005US20050060599 Distributed testing apparatus and host testing apparatus
03/17/2005US20050060101 Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
03/17/2005US20050060100 Computer software and algorithms for systems biologically linked to cellular phenotype
1 ... 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 ... 3937